http://www.healio.com/orthopedics/business-of-orthopedics/news/online/%7Bcf26f334-da87-491c-9d65-c268c3cf1c7a%7D/the-five-most-popular-items-of-november
The five most popular items of November
The five most popular items of November
December 3, 2014
Orthopedics Today has put together a compilation of the five news stories and videos most viewed from November 2014 to keep you abreast of the current hot topics in orthopedics.
Study: No benefit in pain relief, narcotic use seen with liposomal bupivacaine vs bupivacaine alone for TKA
DALLAS — A periarticular injection of liposomal bupivacaine prior to implantation of a total knee did not lead to a significant reduction in pain or decreased narcotic use compared with bupivacaine alone, according to results of a study presented at the American Association of Hip and Knee Surgeons Annual Meeting. Read more.
Several risk factors linked with postoperative knee stiffness requiring manipulation after TKA
Statistically significant risk factors for postoperative knee stiffness that required manipulation under anesthesia after total knee arthroplasty included black race, female gender, age, obesity and nicotine dependence, according to study results.Read more.
Trunionosis — Is it an impending epidemic?
DALLAS — Craig J. Della Valle, MD, gives take home messages from his presentation on trunnionosis at the American Association of Hip and Knee Surgeons Annual Meeting. Watch video.
Six important orthopedics videos to watch
Orthopedics Today has highlighted six important videos to keep your practice up-to-date on a multitude of topics in orthopedic medicine. Read more.
Comparable function seen at 6 weeks with direct anterior, posterior approach for THA
DALLAS — Patients had earlier hospital discharge and better pain relief after undergoing total hip arthroplasty performed with a direct anterior approach vs. a posterior approach; however, no significant differences were seen for subjective or objective function at 6 weeks, according to study results presented here. Read more.
asure
Measure
No hay comentarios:
Publicar un comentario